BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2021 5:24:00 AM | Browse: 434 | Download: 729
 |
Received |
|
2021-03-28 00:19 |
|
Peer-Review Started |
|
2021-03-28 00:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-15 22:08 |
|
Revised |
|
2021-07-27 17:57 |
|
Second Decision |
|
2021-11-24 03:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-11-25 02:27 |
|
Articles in Press |
|
2021-11-25 02:27 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-16 11:06 |
|
Publish the Manuscript Online |
|
2021-12-27 05:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ma Ai Thanda Han, Raquel Olivo, Catherine J Choi and Nikolaos Pyrsopoulos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Nikolaos Pyrsopoulos, FAASLD, AGAF, FACG, MD, PhD, Director, Director, Professor, Department of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, 185 South Orange Avenue, H-536, Newark, NJ 07103, United States. pyrsopni@njms.rutgers.edu |
| Key Words |
Metabolic dysfunction-associated fatty liver disease; Metabolic dysfunction-associated steatohepatitis; De novo; Recurrent; Graft steatosis; Fibrosis; Survival |
| Core Tip |
Metabolic dysfunction-associated fatty liver disease (MAFLD) is common after liver transplantation. Post transplant metabolic dysfunction, obesity and consequences of immunosuppressant contribute to the development of either de novo or recurrent graft steatosis. Post liver transplant MAFLD impact on cardiovascular outcome without significant impact on graft and patient survival. Weight control and tailoring of immunosuppression are the main strategies to prevent post liver transplant MAFLD. |
| Publish Date |
2021-12-27 05:24 |
| Citation |
Han MAT, Olivo R, Choi CJ, Pyrsopoulos N. De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation. World J Hepatol 2021; 13(12): 1991-2004 |
| URL |
https://www.wjgnet.com/1948-5182/full/v13/i12/1991.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v13.i12.1991 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
